FTUS
ASBPW

Flow Traders U.S.’s Aspire Biopharma Warrant ASBPW Stock Holding History

Flow Traders U.S.’s Portfolio ASBPW Stock Details ASBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Buy
15,050
+500
+3% +$10 ﹤0.01% 1379
2025
Q4 		$0 Sell
14,550
-339
-2% -$10 ﹤0.01% 1340
2025
Q3 		$0 Buy
14,889
+398
+3% +$20 ﹤0.01% 1334
2025
Q2 		$1K Buy
14,491
+300
+2% +$15 ﹤0.01% 909
2025
Q1 		$1K Buy
+14,191
New +$854 ﹤0.01% 886

Other funds holding ASBPW

MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 18.84% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Flow Traders U.S.'s ASBPW Position: Q1 2026 in Review

Flow Traders U.S. increased its Aspire Biopharma Warrant (ASBPW) stake by 3.4% in Q1 2026, buying an estimated $10 and bringing the position to 15,050 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1379.

Flow Traders U.S. first reported a position in ASBPW in Q1 2025 and has held it in 5 quarters since. The position peaked at $1K in Q2 2025. 29 funds tracked by Wall St. Rank hold ASBPW as of Q1 2026.

  • Flow Traders U.S. held 15,050 shares of Aspire Biopharma Warrant worth $0 as of Q1 2026.
  • Flow Traders U.S. bought 500 Aspire Biopharma Warrant shares in Q1 2026, an estimated $10.
  • Aspire Biopharma Warrant made up ﹤0.01% of Flow Traders U.S.'s portfolio in Q1 2026, its #1379 holding.
  • Flow Traders U.S. first reported a position in Aspire Biopharma Warrant in Q1 2025 and has held it in 5 quarters since.
  • Flow Traders U.S.'s Aspire Biopharma Warrant position peaked at $1K in Q2 2025.
  • 29 funds tracked by Wall St. Rank held Aspire Biopharma Warrant as of Q1 2026.

Based on Flow Traders U.S.'s 13F filing for Q1 2026, filed 15 May 2026.